Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
- PMID: 21289278
- PMCID: PMC3044380
- DOI: 10.1073/pnas.1019393108
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Abstract
Point mutations of the NADP(+)-dependent isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) occur early in the pathogenesis of gliomas. When mutated, IDH1 and IDH2 gain the ability to produce the metabolite (R)-2-hydroxyglutarate (2HG), but the downstream effects of mutant IDH1 and IDH2 proteins or of 2HG on cellular metabolism are unknown. We profiled >200 metabolites in human oligodendroglioma (HOG) cells to determine the effects of expression of IDH1 and IDH2 mutants. Levels of amino acids, glutathione metabolites, choline derivatives, and tricarboxylic acid (TCA) cycle intermediates were altered in mutant IDH1- and IDH2-expressing cells. These changes were similar to those identified after treatment of the cells with 2HG. Remarkably, N-acetyl-aspartyl-glutamate (NAAG), a common dipeptide in brain, was 50-fold reduced in cells expressing IDH1 mutants and 8.3-fold reduced in cells expressing IDH2 mutants. NAAG also was significantly lower in human glioma tissues containing IDH mutations than in gliomas without such mutations. These metabolic changes provide clues to the pathogenesis of tumors associated with IDH gene mutations.
Conflict of interest statement
Conflict of interest statement: Under agreements between the Johns Hopkins University, Agios Pharmaceuticals, and Personal Genome Diagnostics, B.V. is entitled to a share of the royalties received by the University on sales of products related to IDH genes. B.V. is a cofounder of Personal Genome Diagnostics and is a member of its Scientific Advisory Board. B.V. also owns stock in Personal Genome Diagnostics, which is subject to certain restrictions under University policy. The terms of these arrangements are managed by the Johns Hopkins University in accordance with its conflict-of-interest policies.
Figures





Similar articles
-
2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations.PLoS One. 2011 Feb 4;6(2):e16812. doi: 10.1371/journal.pone.0016812. PLoS One. 2011. PMID: 21326614 Free PMC article.
-
Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism.J Neurochem. 2015 Jan;132(2):183-93. doi: 10.1111/jnc.12950. Epub 2014 Nov 2. J Neurochem. 2015. PMID: 25251602
-
The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization.J Biol Chem. 2013 Feb 8;288(6):3804-15. doi: 10.1074/jbc.M112.435495. Epub 2012 Dec 21. J Biol Chem. 2013. PMID: 23264629 Free PMC article.
-
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.J Natl Cancer Inst. 2010 Jul 7;102(13):932-41. doi: 10.1093/jnci/djq187. Epub 2010 May 31. J Natl Cancer Inst. 2010. PMID: 20513808 Free PMC article. Review.
-
Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer.Curr Top Med Chem. 2018;18(6):505-524. doi: 10.2174/1568026618666180518091144. Curr Top Med Chem. 2018. PMID: 29773061 Review.
Cited by
-
Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia.Cancer Prev Res (Phila). 2012 Dec;5(12):1358-67. doi: 10.1158/1940-6207.CAPR-12-0160. Epub 2012 Sep 7. Cancer Prev Res (Phila). 2012. PMID: 22961778 Free PMC article.
-
GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells.Antioxidants (Basel). 2024 Jun 20;13(6):745. doi: 10.3390/antiox13060745. Antioxidants (Basel). 2024. PMID: 38929183 Free PMC article. Review.
-
Oncometabolites: tailoring our genes.FEBS J. 2015 Aug;282(15):2796-805. doi: 10.1111/febs.13295. Epub 2015 Apr 30. FEBS J. 2015. PMID: 25864878 Free PMC article. Review.
-
From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas.Cells. 2021 May 17;10(5):1225. doi: 10.3390/cells10051225. Cells. 2021. PMID: 34067729 Free PMC article. Review.
-
Genome-wide association studies of five free amino acid levels in rice.Front Plant Sci. 2022 Nov 7;13:1048860. doi: 10.3389/fpls.2022.1048860. eCollection 2022. Front Plant Sci. 2022. PMID: 36420042 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous